Private Wealth Asset Management LLC Reduces Holdings in Danaher Corporation $DHR
by Teresa Graham · The Cerbat GemPrivate Wealth Asset Management LLC lowered its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 21.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 919 shares of the conglomerate’s stock after selling 245 shares during the period. Private Wealth Asset Management LLC’s holdings in Danaher were worth $182,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently added to or reduced their stakes in the company. Hills Bank & Trust Co increased its position in shares of Danaher by 0.3% in the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock valued at $3,693,000 after buying an additional 53 shares in the last quarter. Worth Financial Advisory Group LLC increased its holdings in Danaher by 4.6% during the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after acquiring an additional 53 shares in the last quarter. Sageworth Trust Co raised its position in Danaher by 2.3% during the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate’s stock worth $493,000 after acquiring an additional 54 shares during the last quarter. 1834 Investment Advisors Co. lifted its holdings in shares of Danaher by 3.3% in the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 54 shares in the last quarter. Finally, Bruce G. Allen Investments LLC lifted its holdings in shares of Danaher by 13.1% in the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock valued at $92,000 after purchasing an additional 54 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Danaher
In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. 11.10% of the stock is currently owned by insiders.
Danaher Stock Up 0.1%
Shares of NYSE:DHR opened at $206.32 on Thursday. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The firm has a market cap of $147.73 billion, a price-to-earnings ratio of 43.90, a PEG ratio of 2.94 and a beta of 0.77. The stock’s 50-day moving average price is $201.18 and its two-hundred day moving average price is $197.19. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.41.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the prior year, the company posted $1.72 EPS. The company’s quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on DHR. Royal Bank Of Canada set a $241.00 price objective on Danaher in a research report on Tuesday, September 2nd. Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a research report on Friday, July 11th. Wells Fargo & Company cut their target price on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 23rd. Finally, Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Seventeen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $244.60.
Read Our Latest Stock Analysis on Danaher
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- The Most Important Warren Buffett Stock for Investors: His Own
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead